APOA5 and metabolic dysfunction-associated steatotic liver disease: This could be explained in that this variant has been related to a decrease in hepatic ApoA5 secretion [27] and high hepatic ApoA5 concentrations have been observed in liver biopsies of NAFLD patients and in animal models [28,29].